Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Stock par value $0.012 per share
-
Shares outstanding
-
41M
-
Number of holders
-
73
-
Total 13F shares, excl. options
-
3.84M
-
Shares change
-
+2.61M
-
Total reported value, excl. options
-
$51.4M
-
Value change
-
+$35.1M
-
Put/Call ratio
-
0.35
-
Number of buys
-
54
-
Number of sells
-
-15
-
Price
-
$13.38
Significant Holders of ORAMED PHARMACEUTICALS INC. - Common Stock par value $0.012 per share (ORMP) as of Q2 2021
85 filings reported holding ORMP - ORAMED PHARMACEUTICALS INC. - Common Stock par value $0.012 per share as of Q2 2021.
ORAMED PHARMACEUTICALS INC. - Common Stock par value $0.012 per share (ORMP) has 73 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3.84M shares
of 41M outstanding shares and own 9.37% of the company stock.
Largest 10 shareholders include BlackRock Inc. (1.27M shares), STATE STREET CORP (352K shares), MORGAN JESS S & CO INC (322K shares), GEODE CAPITAL MANAGEMENT, LLC (218K shares), NORTHERN TRUST CORP (211K shares), MILLENNIUM MANAGEMENT LLC (201K shares), VANGUARD GROUP INC (125K shares), Nuveen Asset Management, LLC (91.9K shares), MORGAN STANLEY (82.7K shares), and Frontier Wealth Management LLC (72.6K shares).
This table shows the top 73 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.